Does ENTRECTINIB Cause Off label use? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Off label use have been filed in association with ENTRECTINIB (Rozlytrek). This represents 9.2% of all adverse event reports for ENTRECTINIB.
137
Reports of Off label use with ENTRECTINIB
9.2%
of all ENTRECTINIB reports
20
Deaths
10
Hospitalizations
How Dangerous Is Off label use From ENTRECTINIB?
Of the 137 reports, 20 (14.6%) resulted in death, 10 (7.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENTRECTINIB. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
Nausea (56)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ENTRECTINIB Alternatives Have Lower Off label use Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE